Literature DB >> 7536259

International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms.

G E van Venrooij1, T A Boon, R P de Gier.   

Abstract

In 207 men with symptomatic benign prostatic hyperplasia the international prostate symptom score and score on quality of life were collected. Cystometric tests with pressure-flow studies were performed in these patients with special attention to the assessment of obstruction grade. Of the men 24% appeared not to have obstruction. A significant correlation was found between size of the prostate and grade of obstruction. No correlation was found between obstruction grade, and any symptom score or quality of life score, while symptom score and quality of life correlated well. In 41 patients the outcome of laser prostatectomy was evaluated 6 months after the procedure. Mean symptom score decreased from 19.1 to 5.4 and mean quality of life score decreased from 3.7 to 1.3 in the 31 obstruction patients, compared to decreases of 19.6 to 10.1 and 3.6 to 2.6, respectively, in 10 without obstruction. The improvement in the obstruction patients was significantly better but nonobstruction patients will benefit from prostatectomy as well.

Entities:  

Mesh:

Year:  1995        PMID: 7536259     DOI: 10.1097/00005392-199505000-00046

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  The competing effects of disease states on quality of life of the elderly: the case of urinary symptoms in men.

Authors:  B Mozes; Y Maor; A Shmueli
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

2.  Longitudinal evaluation of the SF-36 quality of life questionnaire in patients with kidney stones.

Authors:  Chester J Donnally; Amit Gupta; Karim Bensalah; Altug Tuncel; Jay Raman; Margaret S Pearle; Yair Lotan
Journal:  Urol Res       Date:  2010-10-06

Review 3.  Benign prostatic hyperplasia.

Authors:  A Melville; J Donovon; T Sheldon; T Peters
Journal:  Qual Health Care       Date:  1996-06

4.  [Benign prostate hyperplasia].

Authors:  U Jonas; A I Gabouev; T R W Herrmann; K Höfner; M C Michel; M Alschibaja; R Hartung
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

5.  Urodynamically diagnosed detrusor hypocontractility: should transurethral resection of the prostate be contraindicated?

Authors:  Rubiao Ou; Chaojie Pan; Hui Chen; Suishan Wu; Xinghua Wei; Xiangrong Deng; Ping Tang; Keji Xie
Journal:  Int Urol Nephrol       Date:  2011-06-10       Impact factor: 2.370

6.  The American Urological Association Symptom Index: early postoperative evaluation of irritative and obstructive symptoms due to benign prostatic hyperplasia.

Authors:  O Ichiyanagi; M Ishigooka; T Hashimoto; S Hayani; Y Suzuki; T Nakada
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

Review 7.  Acetylcholine for male LUTS.

Authors:  Steven J Weissbart; Bilal Chughtai; Dean Elterman; Richard Lee; Alexis Te; Steven Kaplan
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

8.  A prospective video-controlled study of genito-urinary disorders in 35 consecutive laparoscopic TMEs for rectal cancer.

Authors:  Andrea Costanzi; Luca Rigamonti; Giulio Maria Mari; Angelo Miranda; Jacopo Crippa; Valter Berardi; Dario Maggioni
Journal:  Surg Endosc       Date:  2014-10-11       Impact factor: 4.584

9.  Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.

Authors:  M Ozgür Tan; Ilhan Karabiyik; M Cemil Uygur; Yusuf Diker; Demokan Erol
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

10.  Non-invasive clinical parameters for the prediction of urodynamic bladder outlet obstruction: analysis using causal Bayesian networks.

Authors:  Myong Kim; Abhilash Cheeti; Changwon Yoo; Minsoo Choo; Jae-Seung Paick; Seung-June Oh
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.